{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:02:29Z","timestamp":1778691749411,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006792","name":"Hartwell Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019408","name":"Marcus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019408","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jcyt.2023.11.006","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T16:05:09Z","timestamp":1701878709000},"page":"185-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mesenchymal stromal cells suppress microglial activation and tumor necrosis factor production"],"prefix":"10.1016","volume":"26","author":[{"given":"Li","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5823-6780","authenticated-orcid":false,"given":"Hyunjung","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun","family":"Saha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aruni","family":"Gunaratne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Schwartzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4245-611X","authenticated-orcid":false,"given":"Roberta","family":"Parrott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3370-0703","authenticated-orcid":false,"given":"Joanne","family":"Kurtzberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4329-0151","authenticated-orcid":false,"given":"Anthony J.","family":"Filiano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2023.11.006_bib0001","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.it.2021.04.003","article-title":"Neuroimmune cleanup crews in brain injury","volume":"42","author":"Bolte","year":"2021","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0002","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2023.03.008","article-title":"Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting","volume":"186","author":"Charabati","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0003","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/jnr.23804","article-title":"Neuroimmune mechanisms in Krabbe's disease","volume":"94","author":"Potter","year":"2016","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0004","doi-asserted-by":"crossref","first-page":"2009-2026","DOI":"10.1007\/s12035-021-02700-7","article-title":"Recent Investigations on Neurotransmitters\u2019 Role in Acute White Matter Injury of Perinatal Glia and Pharmacotherapies\u2013Glia Dynamics in Stem Cell Therapy","volume":"59","author":"Beeraka","year":"2022","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0005","article-title":"Mechanism of White Matter Injury and Promising Therapeutic Strategies of MSCs After Intracerebral Hemorrhage","volume":"13","author":"Li","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0006","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/stem.2779","article-title":"Immunomodulation By Therapeutic Mesenchymal Stromal Cells (MSC) Is Triggered Through Phagocytosis of MSC By Monocytic Cells","volume":"36","author":"de Witte","year":"2018","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0007","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/stem.2372","article-title":"Mitochondrial Transfer via Tunneling Nanotubes is an Important Mechanism by Which Mesenchymal Stem Cells Enhance Macrophage Phagocytosis in the In Vitro and In Vivo Models of ARDS","volume":"34","author":"Jackson","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0008","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/stem.3292","article-title":"Mesenchymal stromal cells reprogram monocytes and macrophages with processing bodies","volume":"39","author":"Min","year":"2021","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0009","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7828","article-title":"Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation","volume":"9","author":"Galleu","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0010","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"Nemeth","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0011","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13578-020-00475-3","article-title":"Treatment of spinal cord injury with mesenchymal stem cells","volume":"10","author":"Liau","year":"2020","journal-title":"Cell Biosci"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102200","article-title":"Mesenchymal stem cells in experimental autoimmune encephalomyelitis model of multiple sclerosis: A systematic review and meta-analysis","volume":"44","author":"Yanwu","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0013","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41583-023-00709-6","article-title":"Roles and regulation of microglia activity in multiple sclerosis: insights from animal models","volume":"24","author":"Distefano-Gagne","year":"2023","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0014","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","article-title":"A lymphocyte\u2013microglia\u2013astrocyte axis in chronic active multiple sclerosis","volume":"597","author":"Absinta","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0015","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1002\/glia.23963","article-title":"Microglial inflammasome activation drives developmental white matter injury","volume":"69","author":"Holloway","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0016","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1742-2094-9-156","article-title":"Clusters of activated microglia in normal-appearing white matter show signs of innate immune activation","volume":"9","author":"van Horssen","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0017","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/cns.13266","article-title":"Heterogeneity of microglia and their differential roles in white matter pathology","volume":"25","author":"Lee","year":"2019","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0018","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41419-023-05551-3","article-title":"Microglia and meningeal macrophages depletion delays the onset of experimental autoimmune encephalomyelitis","volume":"14","author":"Montilla","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0019","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.expneurol.2018.05.021","article-title":"Csf1R inhibition attenuates experimental autoimmune encephalomyelitis and promotes recovery","volume":"307","author":"Nissen","year":"2018","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0020","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/glia.23980","article-title":"Activated microglia drive demyelination via CSF1R signaling","volume":"69","author":"Marzan","year":"2021","journal-title":"Glia"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0021","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/stem.3380","article-title":"Macrophages at the nexus of mesenchymal stromal cell potency: The emerging role of chemokine cooperativity","volume":"39","author":"Galipeau","year":"2021","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0022","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1089\/neu.2011.2109","article-title":"Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury","volume":"29","author":"Nakajima","year":"2012","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0023","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/stcltm\/szad027","article-title":"A Pilot Phase I Trial of Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells in Neonates With Hypoxic\u2013Ischemic Encephalopathy","volume":"12","author":"Cotten","year":"2023","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0024","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/stcltm\/szad009","article-title":"Feasibility Study of Cord Tissue Derived Mesenchymal Stromal Cells in COVID-19-Related Acute Respiratory Distress Syndrome","volume":"12","author":"Shaz","year":"2023","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0025","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/dmcn.15325","article-title":"Motor function and safety after allogeneic cord blood and cord tissue-derived mesenchymal stromal cells in cerebral palsy: An open-label, randomized trial","volume":"64","author":"Sun","year":"2022","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0026","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/sctm.19-0434","article-title":"Infusion of human umbilical cord tissue mesenchymal stromal cells in children with autism spectrum disorder","volume":"9","author":"Sun","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0027","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nn.4528","article-title":"Regulatory T cells promote myelin regeneration in the central nervous system","volume":"20","author":"Dombrowski","year":"2017","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0028","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.mcn.2003.10.014","article-title":"Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination","volume":"25","author":"Woodruff","year":"2004","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0029","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12974-023-02721-0","article-title":"Regulatory T cells alleviate myelin loss and cognitive dysfunction by regulating neuroinflammation and microglial pyroptosis via TLR4\/MyD88\/NF-kappaB pathway in LPC-induced demyelination","volume":"20","author":"Wang","year":"2023","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00401-021-02389-x","article-title":"White matter microglia heterogeneity in the CNS","volume":"143","author":"Amor","year":"2022","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0031","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12974-021-02360-3","article-title":"Citrullinated myelin induces microglial TNFalpha and inhibits endogenous repair in the cuprizone model of demyelination","volume":"18","author":"Standiford","year":"2021","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0032","first-page":"23","article-title":"Microglial process convergence on axonal segments in health and disease","volume":"7","author":"Benusa","year":"2020","journal-title":"Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0033","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40478-015-0203-5","article-title":"Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis","volume":"3","author":"Holtman","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0034","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/s41590-023-01522-0","article-title":"Defining blood-induced microglia functions in neurodegeneration through multiomic profiling","volume":"24","author":"Mendiola","year":"2023","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0035","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.neuron.2017.04.043","article-title":"Diverse Requirements for Microglial Survival, Specification, and Function Revealed by Defined-Medium Cultures","volume":"94","author":"Bohlen","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0036","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4049\/immunohorizons.2000101","article-title":"Physiology of Cultured Human Microglia Maintained in a Defined Culture Medium","volume":"5","author":"Tewari","year":"2021","journal-title":"Immunohorizons"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0037","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12974-016-0484-z","article-title":"Characterization of a novel adult murine immortalized microglial cell line and its activation by amyloid-beta","volume":"13","author":"McCarthy","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0038","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jcyt.2017.03.076","article-title":"Regulatory perspective on in vitro potency assays for human mesenchymal stromal cells used in immunotherapy","volume":"19","author":"de Wolf","year":"2017","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0039","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jcyt.2014.10.002","article-title":"A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression","volume":"17","author":"Bloom","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0040","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.jcyt.2015.08.008","article-title":"Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potency","volume":"17","author":"Salem","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0041","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jcyt.2015.07.008","article-title":"Research using Mesenchymal Stem\/Stromal Cells: quality metric towards developing a reference material","volume":"17","author":"Tanavde","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0042","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1089\/scd.2013.0591","article-title":"Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation","volume":"23","author":"Viswanathan","year":"2014","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0043","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13287-021-02697-9","article-title":"The application of mesenchymal stromal cells (MSCs) and their derivative exosome in skin wound healing: a comprehensive review","volume":"13","author":"Bian","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0044","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3389\/fimmu.2019.01191","article-title":"Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs","volume":"10","author":"Weiss","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0046","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/stmcls\/sxad019","article-title":"Revisiting the Mesenchymal \u201cStem vs. Stromal\u201d Cell Dichotomy and Its Implications for Development of Improved Potency Metrics","volume":"41","author":"Phinney","year":"2023","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0047","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/j.celrep.2018.02.013","article-title":"Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach","volume":"22","author":"Chinnadurai","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0048","article-title":"Current Knowledge of Microglia in Traumatic Spinal Cord Injury","volume":"12","author":"Xu","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0049","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/NEN.0000000000000021","article-title":"Progressive neurodegeneration after experimental brain trauma: association with chronic microglial activation","volume":"73","author":"Loane","year":"2014","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13024-022-00584-2","article-title":"Single-cell microglial transcriptomics during demyelination defines a microglial state required for lytic carcass clearance","volume":"17","author":"Zia","year":"2022","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0051","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0052","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuroscience.2015.06.038","article-title":"TNF and its receptors in the CNS: The essential, the desirable and the deleterious effects","volume":"302","author":"Probert","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0053","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1177\/0271678X15610339","article-title":"Genetic ablation of soluble tumor necrosis factor with preservation of membrane tumor necrosis factor is associated with neuroprotection after focal cerebral ischemia","volume":"36","author":"Madsen","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0054","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3389\/fnins.2019.00781","article-title":"Topical Administration of a Soluble TNF Inhibitor Reduces Infarct Volume After Focal Cerebral Ischemia in Mice","volume":"13","author":"Yli-Karjanmaa","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0055","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1097\/00001756-200009110-00035","article-title":"Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation","volume":"11","author":"Chopp","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0056","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/neu.2018.5835","article-title":"Exosomes Derived from Bone Mesenchymal Stem Cells Repair Traumatic Spinal Cord Injury by Suppressing the Activation of A1 Neurotoxic Reactive Astrocytes","volume":"36","author":"Liu","year":"2019","journal-title":"J Neurotrauma"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0057","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/stem.1174","article-title":"Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1","volume":"30","author":"Giunti","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0058","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.5966\/sctm.2015-0217","article-title":"Mesenchymal Stem Cells Modulate the Functional Properties of Microglia via TGF-\u03b2 Secretion","volume":"5","author":"Noh","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2019.146422","article-title":"Mesenchymal stem cells enhance microglia M2 polarization and attenuate neuroinflammation through TSG-6","volume":"1724","author":"Liu","year":"2019","journal-title":"Brain Res"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113347","article-title":"Mesenchymal stem cells target microglia via galectin-1 production to rescue aged mice from olfactory dysfunction","volume":"153","author":"Seo","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0061","first-page":"1657","article-title":"Mesenchymal stem cell-derived exosomes regulate microglia phenotypes: a promising treatment for acute central nervous system injury","volume":"18","author":"Liu","year":"2023","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0062","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12974-014-0149-8","article-title":"Mesenchymal stem cells exert anti-proliferative effect on lipopolysaccharide-stimulated BV2 microglia by reducing tumour necrosis factor-alpha levels","volume":"11","author":"Jose","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0063","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1089\/scd.2014.0088","article-title":"Regulation of mouse microglia activation and effector functions by bone marrow-derived mesenchymal stem cells","volume":"23","author":"Hegyi","year":"2014","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0064","doi-asserted-by":"crossref","first-page":"eaay6324","DOI":"10.1126\/sciadv.aay6324","article-title":"Microglia response following acute demyelination is heterogeneous and limits infiltrating macrophage dispersion","volume":"6","author":"Plemel","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.jcyt.2023.11.006_bib0065","first-page":"e1989","article-title":"Protocol for Primary Microglial Culture Preparation","volume":"6","author":"Lian","year":"2016","journal-title":"Bio Protoc"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923011052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923011052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:51:55Z","timestamp":1761443515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324923011052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1465324923011052"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.11.006","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mesenchymal stromal cells suppress microglial activation and tumor necrosis factor production","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}